Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers led by Professor Irene Tracey of the Nuffield Department of Clinical Neurosciences have discovered how to get the clearest picture yet of degrees of perceptual awareness in the brain during the period of anaesthesia.

Listen to Professor Irene Tracey on BBC Radio 4

This research could lead to the first personalised method for administering appropriate doses of anaesthetic during operations and potentially reduce the risks associated with being under a general anaesthetic. Professor Hugh Perry, Chair of the Neurosciences and Mental Health Board at the Medical Research Council, said: ‘With the growing use of anaesthetics in the elderly and other at-risk groups, understanding the minimal dose required to induce the necessary level of anaesthesia is hugely important.’

The work was carried out at the centre for Functional Magnetic Resonance Imaging of the Brain (FMRIB) and was funded by the Medical Research Council, the Wellcome Trust, International Anesthesia Research Society and the National Institute of Academic Anaesthesia. The results are published online today in the journal Science Translational Medicine.

The research team administered a standard anaesthetic over an extended period of time to 16 subjects. They exposed the subjects to different kinds of stimuli, while recording the brain’s electrical activity using electroencephalography (EEG). They found that there were common patterns of behaviour among the group as they lost consciousness – but that these behaviours happened at different times unique to each individual. Beyond the stage where the subjects stopped responding to standard external stimuli, they all reached a state where the slow-wave activity in the brain stayed the same, even as higher doses of anaesthetic were given. 

The researchers also identified a relationship between slow-wave saturation amplitude and grey matter volume in the frontal parts of the subjects’ brains. Using a combination of EEG and functional magnetic resonance imaging (fMRI), the team measured slow-wave brain activity in the group. The fMRI data helped reveal that at the point of ‘saturation’ of the slow-wave activity, the brain became ‘isolated’ from the external world. In other words, the brain regions that would usually be expected to respond to standard stimuli were no longer activated. This indicates that there is an optimum depth of anaesthesia producing perception loss beyond which further anaesthetic is not needed.

Professor Irene Tracey, Director of FMRIB and senior author of the paper, said: ‘Despite the hundreds of thousands of anaesthetics administered daily to patients, remarkably there is no robust, individualised indicator of perceptual awareness available. While we can indirectly gauge whether a patient physically responds to their environment, this imaging method offers a much more nuanced approach. The next stage in the development of this method will be to see if it is similarly illuminating when we monitor anaesthetised patients undergoing surgery.’

Listen to Professor Irene Tracey on BBC Radio 4

Similar stories

Oxford researchers uncover how Parkinson's disease protein damages brain cells

A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Success for NDCN teams at the Vice-Chancellor's Awards 2026

The Vice-Chancellor’s Awards, which recognise achievements and celebrate success across the collegiate University, were announced at a special ceremony hosted by the VC at the Schwarzman’s Sohmen Concert Hall on Thursday 4 June

Two researchers from NDCN join global network to unravel the complexity of Parkinson’s disease

Two scientists from NDCN, Professor Andrew Sharott (Team leader) and Professor Laura Parkkinen (Co-Investigator) have been selected for multi-year grants to join the Collaborative Research Network (CRN) an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease.

Study shows that non-invasive ultrasound shows promise for treating Parkinson’s disease

Oxford researchers have shown for the first time that ultrasound could have similar effects on brain activity in Parkinson’s sufferers as implanted deep brain stimulation (DBS) electrodes. This opens the door to new treatment approaches that could avoid surgery.

Collaboration with the Nepal Public Health Foundation (NPHF) explores maternal health and epilepsy

A new study, co-led by Professor Arjune Sen and supported by Nuffield Department of Clinical Neurosciences, aims to improve understanding of the risk factors, care pathways and broader health and social impacts of epilepsy in Nepal.